Amanda Cashen, M.D.
Washington University School of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Amanda Cashen, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:53 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04893915 · Cytokine-induced Memory-like NK Cells in Relapsed/Refractory AML and MDSWashington University School of Medicine · withdrawn · Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes · principal investigator
- Ph2NCT04331119 · Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell LymphomasWashington University School of Medicine · terminated · T-Cell Lymphoma · principal investigator
- Ph1/Ph2NCT03068819 · Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell TransplantWashington University School of Medicine · completed · Acute Myeloid Leukemia · principal investigator
- Ph2NCT02782546 · Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell TransplantationWashington University School of Medicine · active not recruiting · Acute Myeloid Leukemia · principal investigator
- Early Ph1NCT02117115 · Abdominal CT to Predict the Risk of Acute Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell TransplantationWashington University School of Medicine · completed · Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelogenous, Chronic · principal investigator
- Ph2NCT01969435 · Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for LymphomaWashington University School of Medicine · completed · Hodgkin Disease, Lymphoma, Non-Hodgkin · principal investigator
- Ph1/Ph2NCT01898793 · Cytokine-induced Memory-like NK Cells in Patients With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)Washington University School of Medicine · terminated · Leukemia, Myeloid, Acute · principal investigator
- Ph1NCT01001143 · Intravenous (IV) Decitabine and Oral Bexarotene for Acute Myelogenous Leukemia (AML)Washington University School of Medicine · completed · Leukemia, Myeloid, Acute · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:53 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Core A: Biospecimen ProcessingP50CA171963 · NCI · WASHINGTON UNIVERSITY · PI MEAGAN JACOBY · fiscal years 2013 to 2026Named on NCT03068819, NCT02782546
- Mechanisms underlying cytokine-induced memory-like natural killer cell differentiation and maintenance.F32CA200253 · NCI · WASHINGTON UNIVERSITY · PI Melissa Berrien Elliott · fiscal years 2015 to 2017Named on NCT01898793
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in acute myeloid leukemia.